Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO

India_adobe_575x375_20
By Jonathan Breen
23 Oct 2020

Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has won approval for its IPO from India’s securities regulator, according to a source close to the deal.

The issuer got the go ahead from the Securities and Exchange Board of India this week, after first filing a draft red herring prospectus in July, when its Hong Kong-listed parent got approval for the spin off.

Hyderabad-based Gland Pharma is planning to list by mid-November for up ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial